Bacterial vaginosis is a common infection that causes discomfort and odor for many women. Finding effective treatments is important for patient comfort and preventing long-term complications. This study combined data from multiple trials to see if intravaginal vitamin C works better than existing options. The researchers focused on nonpregnant patients who were not taking other specific medications during the study period. Understanding these results helps patients discuss options with their doctors.
Researchers analyzed data from 1,107 nonpregnant patients who had bacterial vaginosis. The participants received either intravaginal vitamin C, a placebo, or metronidazole, a common antibiotic. The vitamin C treatment involved using 250 mg daily for six days. The main goal was to see if this approach helped clear the infection quickly and kept it away longer. The study looked at outcomes over one to three weeks and again at six months.
The results showed promising signs for the vitamin C treatment. In the short term, 66% of patients using vitamin C were cured compared to 42% in the control group. When compared to metronidazole, 62% of those using vitamin C were cured versus 52% in that group. At six months, the vitamin C group had a much lower rate of the infection returning, with only 16% experiencing recurrence compared to 32% in the placebo group. These numbers suggest the treatment could be effective for some patients.
Safety was a key part of the review. The researchers did not report any adverse events, serious side effects, or reasons for patients stopping the treatment. The vitamin C was generally well-tolerated in the studies included in this analysis. This lack of reported harm is encouraging, though more detailed safety data would be helpful from larger trials.
It is important to remember that the certainty of this evidence is low. The study design and the number of trials included limit how confident we can be in these specific numbers. Additional randomized trials are needed, particularly to evaluate recurrence beyond one month. Patients should not change their treatment plans based on this single review alone. Doctors need more data before recommending this as a standard alternative to antibiotics.
For patients right now, this study offers a potential new option to discuss with a healthcare provider. It suggests that intravaginal vitamin C might increase cure rates in the short term and help prevent the infection from coming back. However, because the evidence is limited, it should be viewed as a possibility rather than a proven solution. Always talk to a doctor about the best treatment for your specific situation.